In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Kazia Therapeutics Limited ADR (NASDAQ: KZIA) was $0.57 for the day, up 2.58% from the previous closing price of $0.56. In other words, the price has increased by $2.58 from its previous closing price. On the day, 24.71 million shares were traded. KZIA stock price reached its highest trading level at $0.6765 during the session, while it also had its lowest trading level at $0.55.
Ratios:
Our analysis of KZIA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.71 and its Current Ratio is at 0.71. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on October 14, 2021, initiated with a Buy rating and assigned the stock a target price of $18.
On January 05, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $17.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KZIA now has a Market Capitalization of 17050764 and an Enterprise Value of 147663808. Its current Enterprise Value per Revenue stands at 263685.38 whereas that against EBITDA is -8.426.
Stock Price History:
The Beta on a monthly basis for KZIA is 2.31, which has changed by -0.33720928 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, KZIA has reached a high of $1.58, while it has fallen to a 52-week low of $0.19. The 50-Day Moving Average of the stock is 89.79%, while the 200-Day Moving Average is calculated to be 38.12%.
Shares Statistics:
KZIA traded an average of 11.75M shares per day over the past three months and 74367350 shares per day over the past ten days. A total of 23.63M shares are outstanding, with a floating share count of 23.62M. Shares short for KZIA as of 1719532800 were 47130 with a Short Ratio of 0.00, compared to 1717113600 on 26536.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $510k in the next fiscal year. The high estimate is $510k and the low estimate is $510k.
